Why the study?
Does oral torsemide reduce body weight in patients with NYHA class II or III congestive heart failure and edema?
Does oral torsemide reduce body weight in patients with NYHA class II or III congestive heart failure and edema?
Oral torsemide at doses of 10 mg and 20 mg daily is effective and well-tolerated for producing weight loss in patients with symptomatic heart failure and edema.
No takes yet. Share an insight, caveat, or question.
Torsemide 10-20 mg reduces weight in edematous NYHA II-III HF; confirms dose-dependent efficacy and supports titration in practice.
Patterson et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: